Gordon K, Foley P, Rich P, Duffin K, Pinter A, Griffiths C, Wang M, Vanvoorden V, Staelens F, Ciaravino V, Merola J. Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s17. Available from: https://jofskin.org/33014/index.php/skin/article/view/1170